Olema Pharmaceuticals, Inc. (OLMA)
NASDAQ: OLMA · Real-Time Price · USD
4.890
-0.020 (-0.41%)
At close: Apr 28, 2025, 4:00 PM
4.890
0.00 (0.00%)
Pre-market: Apr 29, 2025, 7:17 AM EDT
Olema Pharmaceuticals Employees
Olema Pharmaceuticals had 96 employees as of December 31, 2024. The number of employees increased by 22 or 29.73% compared to the previous year.
Employees
96
Change (1Y)
22
Growth (1Y)
29.73%
Revenue / Employee
n/a
Profits / Employee
-$1,348,687
Market Cap
334.15M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 96 | 22 | 29.73% |
Dec 31, 2023 | 74 | -12 | -13.95% |
Dec 31, 2022 | 86 | 12 | 16.22% |
Dec 31, 2021 | 74 | 37 | 100.00% |
Dec 31, 2020 | 37 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
OLMA News
- 3 days ago - Olema Oncology Announces New Preclinical Data for OP-3136 Demonstrating Anti-Tumor Activity in Multiple Solid Tumor Models at AACR 2025 - GlobeNewsWire
- 20 days ago - Olema Pharmaceuticals: Maybe Not Differentiated, But Could Find A Niche In A Valuable Market - Seeking Alpha
- 26 days ago - Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 weeks ago - Olema Oncology to Present Preclinical Data for OP-3136, a Potent KAT6 Inhibitor, Demonstrating Anti-Tumor Activity in Multiple Solid Tumor Models at the 2025 AACR Annual Meeting - GlobeNewsWire
- 5 weeks ago - Olema Oncology Reports Fourth Quarter and Full Year 2024 Financial and Operating Results - GlobeNewsWire
- 2 months ago - Olema Oncology Appoints Shawnte M. Mitchell, J.D. - GlobeNewsWire
- 3 months ago - Olema Oncology to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 4 months ago - Olema Oncology to Present at 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire